Imperial College London Diabetes Centre, part of the M42 group, celebrated a highly successful launch of its first Diabetes Education Conference in Dubai on 14 September. Drawing nearly 180 delegates, as well as exhibitors and distinguished speakers, the event surpassed expectations and
M42
As another sign of its expansion, M42, a tech-enabled global health powerhouse, today announced that it has entered into a strategic investment partnership with the UAE’s Ministry of Defence to operate and manage Zayed Military Hospital in Al Batayeh, Sharjah, providing access to world-class healthcare to potentially over three million people across the UAE’s northern […]
Mubadala Health Dubai, part of the M42 group, provides specialized treatment for headaches, enabling sufferers to regain control of their lives. Utilizing the latest research, innovative treatments and a holistic approach, Mubadala Health Dubai’s newly launched Headache Clinic aims to improve the quality of life for patients with headaches and chronic migraines. Recently,
Imperial College London Diabetes Centre (ICLDC), part of the M42 group, announces a series of significant achievements in diabetes treatment and research. This year, nine ICLDC-authored research has been published in high-impact peer-reviewed international journals, solidifying its status as a global leader in diabetes research. Its research has appeared in prestigious
In a move to ensure world-class healthcare is seamlessly available for prospective and new parents across the M42 group, HealthPlus Fertility & Women’s Health Center has launched a comprehensive referral program in collaboration with Danat Al Emarat Hospital for Women & Children. This initiative aims to elevate community health by providing access to specialized
The arrival of a newborn is a moment of unparalleled joy for parents. However, for German couple Tim and Sarah, employees of a UAE-based airline, this joy was tempered by worry when their first child, Kai, was born with a rare and life-threatening congenital condition: Tracheoesophageal Fistula (TEF) with Esophageal Atresia (EA). Sarah’s pregnancy had been […]
M42, a global tech-enabled health powerhouse, has won two prestigious awards at the Bonds, Loans & Sukuk Middle East Awards. M42 secured both the M&A Deal of the Year and the Local Currency Loan Deal of the Year for the strategic acquisition of Diaverum. The accolades demonstrate M42’s leadership in the healthcare industry and its […]
In honor of World No Tobacco Day, M42, a global tech-enabled health powerhouse, is shining a spotlight on combatting tobacco addiction through its extensive network of smoking cessation clinics and programs across the M42 group. The annual awareness day, run by the World Health Organization (WHO), raises awareness about the health risks of tobacco use […]
M42 Managing Director and Group Chief Executive Officer, Hasan Jasem Al Nowais, pledged to take Abu Dhabi’s new innovations to the global stage after a historic live demonstration of a remote telerobotic procedure. Controlled and live-streamed from Abu Dhabi, the procedure was performed on a simulated patient in South Korea, showcasing the immense potential of […]
Imperial College London Diabetes Centre (ICLDC), part of the M42 group, has become the first centre in Abu Dhabi to partner with bookdialysis, the leading online booking engine for holiday dialysis patients. ICLDC now joins a coveted network of top-tier clinics in more than 50 countries listed on the free booking platform, offering global travelers […]
M42, an Abu Dhabi-based, global tech-enabled health powerhouse, has unveiled AIRIS-TB, an AI-powered chest X-ray for tuberculosis (TB) screening centers. The technology, which was revealed at Abu Dhabi Global Healthcare Week, uses advanced AI to detect abnormalities in chest X-rays and instantly flags abnormal results for further review by a radiologist. Developed by M42
M42, a global tech-enabled health powerhouse, has launched the next generation of its open-access generative AI Clinical Large Language Model (LLM), Med42, during Abu Dhabi Global Healthcare Week. Building upon the success of the initial launch, Med42 represents the next evolution in AI-driven health innovation, poised to advance healthcare AI and transform patient care,
The Department of Health – Abu Dhabi (DoH),the regulator of the healthcare sector in the emirate, and M42, a global tech-enabled health powerhouse, have collaborated to launch a groundbreaking initiative and strategic priority, the Abu Dhabi Biobank, with its first offering being the region’s largest hybrid cord blood bank. Reinforcing the Emirate’s position as a
M42, a first-of-its-kind tech-enabled global health powerhouse, has unveiled a new Advisory Board, to impactfully disrupt and transform the global health sector through personalized, preventive and precision tech. Comprising some of the world’s leading health and technology experts in the areas of personal remote care, pharmaceuticals, tech and longevity, the Advisory
M42, a global tech-enabled health powerhouse, has achieved the prestigious Global Healthcare Accreditation (GHA) Certification for Excellence in Medical Travel Patient Experience from the United States for its pioneering approach. With an outstanding overall score of 91 percent, this certification reaffirms M42’s commitment to delivering exceptional care and support
Cleveland Clinic Abu Dhabi, part of the M42 group, has successfully completed a complex heart transplant for Muhammad Al Ketbi suffering from familial cardiomyopathy. The 28-year-old Emirati patient, who had been suffering with heart disease for more than a decade, developed multi-organ failure, and was initially placed on an Extracorporeal membrane oxygenation
A renowned surgeon at Danat Al Emarat Hospital for Women & Children, part of the M42 group, has performed life-changing endometriosis treatment on an international patient using ultrasonic scalpel technology. Twenty-four-year-old Chloe Bremner, from the UK, sought out his expert care after realizing what the world-class facility, coupled with unmatched patient-centered
M42, a leading global health-tech powerhouse, is proud to unveil its lineup of top global health experts to convene on the M42 Main Stage at the inaugural Abu Dhabi Global Healthcare Week 2024 (ADGHW). ADGHW, hosted by the Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, under […]
M42, a first-of-its-kind tech-enabled global health powerhouse, has signed a groundbreaking agreement with AstraZeneca, a global leader in science-led biopharmaceuticals, to advance preventive healthcare and next-generation precision medicine. As AstraZeneca’s clinical genomics partner of choice in the Middle East region, M42 will conduct sequencing of hereditary breast
Mubadala Health Dubai, part of the M42 group, has been successfully accredited by the Joint Commission International (JCI) and now proudly displays the coveted Gold Seal of Approval. This significant achievement marks a milestone for Mubadala Health Dubai as it attains its inaugural JCI accreditation in an impressive timeframe of less than 18 months since […]